Loading...
Derniers dépôts
-
Francesco Galli, Laricia Bragg, Maira Rossi, Daisy Proietti, Laura Perani, et al.. Cell-mediated exon skipping normalizes dystrophin expression and muscle function in a new mouse model of Duchenne Muscular Dystrophy. EMBO Molecular Medicine, 2024, 16 (4), pp.927 - 944. ⟨10.1038/s44321-024-00031-3⟩. ⟨hal-04603972⟩
-
Julia Pereira Lemos, Liliane Patrícia Gonçalves Tenório, Vincent Mouly, Gillian Butler-Browne, Daniella Arêas Mendes-Da-Cruz, et al.. T cell biology in neuromuscular disorders: a focus on Duchenne Muscular Dystrophy and Amyotrophic Lateral Sclerosis. Frontiers in Immunology, 2023, 14, pp.120283. ⟨10.3389/fimmu.2023.1202834⟩. ⟨hal-04603915⟩
-
Angelos Gerassimopoulos, Céline Michaud, Mélanie Gaillet, Cyril Rousseau, Adriana Gonzalez, et al.. Santé et recours aux soins et à la prévention des travailleuses du sexe dominicaines vivant le long du fleuve Maroni. 6e journées des travaux scientifiques des soignant.e.s de Guyane, May 2023, Cayenne, Guyane française. ⟨hal-04585175⟩
-
Joe-Elie Salem, Marie Bretagne, Baptiste Abbar, Sarah Leonard-Louis, Stéphane Ederhy, et al.. Abatacept/Ruxolitinib and Screening for Concomitant Respiratory Muscle Failure to Mitigate Fatality of Immune-Checkpoint Inhibitor Myocarditis. Cancer Discovery, 2023, 13 (5), pp.1100-1115. ⟨10.1158/2159-8290.CD-22-1180⟩. ⟨hal-04578810⟩
-
Antonio Atalaia, Dagmar Wandrei, Nawel Lalout, Rachel Thompson, Adrian Tassoni, et al.. EURO-NMD registry: federated FAIR infrastructure, innovative technologies and concepts of a patient-centred registry for rare neuromuscular disorders. Orphanet Journal of Rare Diseases, 2024, 19 (1), pp.66. ⟨10.1186/s13023-024-03059-3⟩. ⟨hal-04460667⟩
-
Vanessa Ueberschlag-Pitiot, Amalia Stantzou, Julien Messéant, Megane Lemaitre, Daniel Owens, et al.. Gonad-related factors promote muscle performance gain during postnatal development in male and female mice. AJP - Endocrinology and Metabolism, 2017, 313 (1), pp.E12-E25. ⟨10.1152/ajpendo.00446.2016⟩. ⟨hal-03677800⟩
-
Hubert Smeets, Bram Verbrugge, Xavier Bulbena, Liliya Hristova, Julia Vogt, et al.. European Joint Programme on Rare Diseases workshop: LAMA2-muscular dystrophy: paving the road to therapy March 17–19, 2023, Barcelona, Spain. LAMA2-muscular dystrophy: paving the road to therapy, Neuromuscular Disorders, 36, pp.16 - 22, 2024, ⟨10.1016/j.nmd.2024.01.001⟩. ⟨hal-04546346⟩
Nombre de documents
790
Nombre de notices
1 381
widget_cloud
Centronuclear myopathy
Humans
RNA interference
Regeneration
Laminopathies
Myasthenia Gravis MG
Aging
ALS
FSHD
Autoantibodies
Fabry disease
Myotonic dystrophy
Errance diagnostique
Nuclear envelope
Calcium
Lamin A/C
Dystrophin
Satellite cell
Inflammation
OPMD
Trinucleotide repeat expansion
CRISPRi
Myoblasts
Muscle regeneration
Dermatomyositis
Myotonic Dystrophy type 1
Transgenic mouse model
Heart
Skeletal muscle
Exercise
Heart failure
Mouse model
Astrocyte
Rare diseases
Mechanotransduction
CMS
Amyotrophic lateral sclerosis
Gene therapy
Neuromuscular junction
Cytokines
Laminopathy
COVID-19
Myotonic Dystrophy
Animals
Aged
MBNL
Alternative splicing
Myopathy
AAV
Autoimmunity
Myositis
Autophagy
Myogenesis
Male
Cytoskeleton
Glutamate
Cell therapy
Muscle
Thymus
Biomarker
Therapy
Thérapie génique
Myopathies
Clinical trials
Congenital muscular dystrophy
Antisense oligonucleotides
Brain
Muscular dystrophy
Becker muscular dystrophy
Laminopathie
CTG repeat contractions
Neuromuscular diseases
Duchenne muscular dystrophy
Congenital myopathy
Actin
Treatment
Transcriptomics
Biomarkers
Motoneuron
Rare neuromuscular diseases
Neuromuscular disease
Long read sequencing
Lamin A/C LMNA gene
Fibrosis
Dynamin 2
Oxidative stress
DMD
LMNA gene
Cardiomyopathy
Satellite cells
Autoimmune diseases
PABPN1
LMNA
Outcome measures
RNA biology
Myotonic dystrophy type 1
Myasthenia gravis
Dilated cardiomyopathy
Cancer
Genotype phenotype correlation